Paeds · pain-palliative-and-end-of-life-care
Opioid stewardship and complex analgesia
Also known as Paediatric opioid stewardship · Patient- and nurse-controlled analgesia in children · Opioid rotation and equianalgesic conversion in children · Opioid tolerance dependence and weaning · Naloxone for opioid-induced respiratory depression
A fellowship approach to opioid stewardship and complex analgesia in a child: give the right opioid at the right weight-based dose by the right route for the right duration, anchor it on a non-opioid multimodal backbone, monitor with a pain score and a sedation score, rotate with the equianalgesic principle and the incomplete cross-tolerance reduction, and wean after prolonged use to avoid tolerance, withdrawal and opioid-induced hyperalgesia. Morphine is the first-line strong opioid at 0.1 to 0.2 mg per kg intravenously or 0.2 to 0.5 mg per kg orally every four hours. Patient- and nurse-controlled analgesia uses a morphine bolus of 10 to 20 microgram per kg with a 5 to 10 minute lockout and an optional low background infusion. Opioid rotation uses the equianalgesic principle that intravenous morphine converts to oral morphine at the standard equianalgesic ratio, and the calculated new-opioid dose is reduced for incomplete cross-tolerance (the review found no RCTs and calls to standardise conversion ratios); methadone conversion is non-linear and specialist-only. Naloxone for therapeutic over-sedation is 0.5 to 2 microgram per kg intravenously titrated to the respiratory rate. After about a week of continuous opioid, wean by 10 to 20 per cent of the established dose every one to two days. Codeine and tramadol are contraindicated under 12 and after tonsillectomy because a CYP2D6 ultrarapid metaboliser converts the prodrug to a fatal morphine overdose.
Checked against its sources on 14 Oct 2026
On this page
Study tools
Your progress
Saved on this device.
Practise this topic
Target exams
Red flags
- Opioid-induced respiratory depression declares itself at the bedside as a falling respiratory rate, increasing sedation and a small or unreactive pupil. The response is airway and breathing support and naloxone titrated to the respiratory rate — 0.5 to 2 microgram per kg intravenously for therapeutic over-sedation, repeated or infused because the opioid outlasts naloxone.
- When you rotate opioids, the equianalgesic calculation alone over-doses the child. Reduce the calculated new-opioid dose by 25 to 50 per cent for incomplete cross-tolerance, and treat methadone conversion as non-linear and specialist-only.
- A child on a continuous opioid for about a week or more develops tolerance and physical dependence. Abrupt cessation or a too-rapid wean produces withdrawal — irritability, tremor, sweating, tachypnoea, diarrhoea, yawning and hypertonia — scored on the WAT-1 scale.
- Parent-controlled analgesia by proxy is restricted to nurse-controlled analgesia. A parent pressing the button for a child has caused fatal over-sedation, because the safety feedback loop (the sedated child stops pressing) is broken.
- Codeine and tramadol are contraindicated in children under 12 and after tonsillectomy or adenoidectomy: a CYP2D6 ultrarapid metaboliser converts the prodrug to a lethal morphine overdose and the genotype cannot be known at the bedside.
- Pain that worsens as the opioid is increased may be opioid-induced hyperalgesia, not tolerance. The answer is to rotate or reduce the opioid and add an NMDA antagonist, not to escalate the dose.
Life stages
Care settings
Clinical exam formats
Board mappings
- Clinical Sciences — Pharmacology
- Clinical Sciences — Pharmacology 10–12
- Current 2026 PREP curriculum — Learning Objective 1.5.2: Demonstrate safe and quality use of medicines, including opioid prescribing and complex analgesia in children
- Current 2026 PREP curriculum — Learning Objective 2.2.1: Recognise, prioritise and manage an acutely ill infant, child or young person, including the child in severe pain and the child with opioid-induced respiratory depression
- Renewed curriculum for first-year trainees from 2027 — Learning goal 4: Safe and effective prescribing
- Clinical Applications
- Medical Sciences
- Long Cases
- Short Cases
- 7. Patient safety, including safe prescribing
- 4. Professional skills and knowledge: Patient management
- 8. Pharmacology: Lead on the safe and effective use of medicines
- Applied Knowledge in Practice (AKP)
- Theory and Science (TAS)
- Clinical
- History
- Communication
- General Pediatrics Content Outline — Universal Task 4: Management and Treatment
- General Pediatrics Content Outline — Universal Task 7: Patient Safety and Quality Improvement
- General Pediatrics EPA 4: Writing Prescriptions
- Patient Care 5: Patient Management
- Systems-Based Practice 1: Patient Safety
- Practice-Based Learning 2: Reflects on unsafe practice and medication safety
- Medical Expert
- Pediatrics: Foundations EPA #5 — Prescribing medications safely
- Pharmacotherapeutic stewardship and safe medication use
Overview & Definition
Picture the child first. A seven-year-old wakes up after orthopaedic surgery with a backslab on a fractured femur, an opioid infusion running, and a pain score that is climbing. The question at the bedside is not "is this child on an opioid," because they already are — it is whether the opioid is the right drug, at the right dose, for the right duration, with the right monitoring, the right plan to rotate it if it stops working, and the right plan to wean it off. That bundle of judgements is opioid stewardship: the same idea as antibiotic stewardship, applied to the most effective and most dangerous analgesics we have. [10] [11]
An opioid relieves pain by agonising the mu-opioid receptor in the brain and spinal cord. Morphine is the prototype and the first-line strong opioid in children. Complex analgesia is the layer above simple weight-based dosing: it is what you do when a child needs an infusion, a patient- or nurse-controlled analgesia device, a rotation from one opioid to another, a structured wean after prolonged use, or a multimodal plan to spare opioid exposure. The discipline of this topic lives in four stewardship questions the prescriber asks at every handover: is the opioid still needed, is the dose right for the weight and the response, is the child being monitored for over-sedation, and is there a plan to stop it. [1] [11]
The unifying idea is that the opioid is powerful and unforgiving, and most of the harm is preventable. A child who is over-sedated, a child rotated without the cross-tolerance reduction, a child sent home with leftover opioid, and a child whose prolonged infusion is stopped abruptly are all the same failure in different costumes — the opioid was started without a plan for the whole journey. The exam answer is the workflow and the safety boundaries, not the arithmetic of a single dose: weigh, score the pain and the sedation, choose and titrate, monitor, rotate with the cross-tolerance reduction, and wean by a schedule. [10] [12]
References13ShowHide
- [1]Donado C, Solodiuk J, Rangel SJ, et al. Patient- and Nurse-Controlled Analgesia: 22-Year Experience in a Pediatric Hospital Hospital Pediatrics, 2019.PMID 30655310
- [2]Walker SM, Selers EL, Jay MA, et al. Intravenous opioids for chemotherapy-induced severe mucositis pain in children: Systematic review and single-center case series of management with patient- or nurse-controlled analgesia (PCA/NCA) Paediatric Anaesthesia, 2022.PMID 34731511
- [3]Kinoshita M, Borges do Nascimento IJ, Styrmisdóttir L, et al. Systemic opioid regimens for postoperative pain in neonates Cochrane Database of Systematic Reviews, 2023.PMID 37018131
- [4]Bichaff P, Setani KT, Motta EHG, et al. Opioid tapering and weaning protocols in pediatric critical care units: a systematic review Revista da Associacao Medica Brasileira, 2018.PMID 30517238
- [5]Steineck KJ, Skoglund AK, Carlson MK, et al. Evaluation of a pharmacist-managed methadone taper Pediatric Critical Care Medicine, 2014.PMID 24448326
- [6]Wilson AK, Ragsdale CE, Sehgal I, et al. Exposure-Based Methadone and Lorazepam Weaning Protocol Reduces Wean Length in Children The Journal of Pediatric Pharmacology and Therapeutics, 2021.PMID 33424499
- [7]Quigley C Opioid switching to improve pain relief and drug tolerability Cochrane Database of Systematic Reviews, 2004.PMID 15266542
- [8]Bateman JT, Saunders SE, Levitt ES, et al. Understanding and countering opioid-induced respiratory depression British Journal of Pharmacology, 2023.PMID 34089181
- [9]Saari TI, Strang J, Dale O, et al. Clinical Pharmacokinetics and Pharmacodynamics of Naloxone Clinical Pharmacokinetics, 2024.PMID 38485851
- [10]Hadland SE, Agarwal R, Raman SR, et al. Opioid Prescribing for Acute Pain Management in Children and Adolescents in Outpatient Settings: Clinical Practice Guideline Pediatrics, 2024.PMID 39344439
- [11]Chou R, Gordon DB, de Leon-Casasola OA, et al. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council The Journal of Pain, 2016.PMID 26827847
- [12]Norris S, Minkowitz S, Scharbach K, et al. Pediatric Palliative Care Primary Care, 2019.PMID 31375193
- [13]Tobias JD, Green TP, Coté CJ, et al. Codeine: Time to Say "No". Pediatrics, 2016.PMID 27647717